Myocardial hypertrophy is characterized by an enlargement in cell size and increased expression of embryonic genes, including ANP, BNP, and β-MHC, which can be considered three biomarkers of cardiomyocyte hypertrophy [39,40]. The gene discussed is NPPA; the disease is cardiac hypertrophy.